Clinical Trials Directory

Trials / Completed

CompletedNCT02802722

Does Vitamin D Supplementation Enhance Resolution of Inflammation After Community-acquired Pneumonia?

A Prospective Randomised Placebo-controlled Study of the Influence of Vitamin D Supplementation on Resolution of Inflammation Following Community-acquired Pneumonia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Queen Mary University of London · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Previous research has shown that people who have been hospitalised for pneumonia are more likely to die of conditions such as heart attacks, stroke and cancer in the weeks to months after their illness. This risk is linked to raised levels of inflammation. Laboratory research shows that vitamin D can help to clear inflammation. Vitamin D deficiency is very common in the United Kingdom. The investigators are conducting this study to find out if taking vitamin D can hasten long-term recovery from pneumonia by reducing inflammation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin D3 supplementationCapsules to be dispensed using an electronic dispenser to allow real time logging of adherence.
BIOLOGICALPeripheral blood and induced sputum samplingTo attain samples for immunological testing
RADIATIONChest computerised tomography (CT) scansFor volumetric quantification of lung abnormalities
OTHERSymptom questionnaireSymptom questionnaire for recent symptom history
OTHERPlaceboTo be dispensed using an electronic dispenser to allow real time logging of adherence.

Timeline

Start date
2017-02-24
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2016-06-16
Last updated
2024-04-19

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02802722. Inclusion in this directory is not an endorsement.